Vaccinex is a cutting-edge biotechnology company specializing in developing novel antibody therapies for cancer and neurodegenerative diseases. With a focus on precision medicine and innovative drug discovery approaches, Vaccinex is at the forefront of revolutionizing the treatment options for patients worldwide.
